BDR Pharma launches Favipiravir at ₹63 per tablet for treatment of COVID-19
NEW DELHI : BDR Pharmaceuticals, a Mumbai based drug company, on Wednesday announced the launched its antiviral drug Favipiravir for the treatment of coronavirus patients in India. The drug has…